Connection

Robert Harrington to Cyclooxygenase Inhibitors

Back to Details
This is a "connection" page, showing publications Robert Harrington has written about Cyclooxygenase Inhibitors.
Robert Harrington
Connection Strength
0.057
Cyclooxygenase Inhibitors
  1. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet. 2004 Aug 21-27; 364(9435):675-84.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.